Foley is pleased to be a Gold sponsor of the Sino-American Biomedical and Pharmaceutical Association (SABPA) 5th Annual Pacific Forum. The conference brings together entrepreneurs, scientists, investors, executives, and policy makers to promote life sciences and biotechnology alliances across the Pacific Rim, including the U.S. West coast, greater China region, and Singapore.
Foley Partner Stephen Bent will participate on a panel discussion on November 7th at 2:30 p.m. on “What is Your China Play – Doing Business in a Shifting Regulatory, Investment, and Economic Environment.”
For more information about the SABPA 5th Annual Pacific Forum, please visit the SABPA Web site.
People
Related Insights
July 22, 2025
Health Care Law Today
GLP-1 Receptor Agonists: Clinical Trial Considerations
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
July 21, 2025
Energy Current
DOE Announces Pilot Program to Build Advanced U.S. Nuclear Fuel Supply Lines: What You Need to Know Now
Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in…
July 21, 2025
Labor & Employment Law Perspectives
Considering a Reduction in Force? Some Preliminary Considerations
Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs…